Afuresertib Withdrawn Phase 2 Trials for Cancer Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01445587A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma